Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LifeMDLFMD -3.63%73 Equity-to-Asset is 0.13 as of Jun. 2026. GuruFocus rates LFMD with a GF Score™ of 73/100 and a GF Value™ of $5.11 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 684 Healthcare Providers & Services companies, LifeMD ranks worse than 87.13% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. LifeMD's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $8.0 Mil. LifeMD's Total Assets for the quarter that ended in Jun. 2026 was $59.9 Mil.
Therefore, LifeMD's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.13.
The historical rank and industry rank for LifeMD's Equity-to-Asset or its related term are showing as below:
LFMD'
s Equity-to-Asset Range Over the Past 10 Years
Min: -1.48 Med: -0.02 Max: 0.94
Current: 0.13
During the past 13 years, the highest Equity to Asset Ratio of LifeMD was 0.94. The lowest was -1.48. And the median was -0.02.
LFMD's Equity-to-Asset is ranked worse than 87.13% of 684
companies
in the Healthcare Providers & Services industry
Industry Median: 0.48
vs LFMD: 0.13
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
LifeMD Equity-to-Asset Related Terms
LifeMD Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for LifeMD's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LFMD vs AMWL, SY, HCAT: Equity-to-Asset Comparison
For the Health Information Services subindustry, LifeMD's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeMD Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LifeMD's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where LifeMD's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
LifeMD's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LifeMD (LFMD) has a Equity-to-Asset of 0.13 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on LifeMD and its competitors. According to the industry distribution chart, LifeMD ranks #596 out of 684 companies in the Healthcare Providers & Services industry, placing it in the top 87.1%.
Is LifeMD's Equity-to-Asset too high?
LifeMD's current Equity-to-Asset is 0.13. The Healthcare Providers & Services industry median Equity-to-Asset is 0.48. LifeMD's value of 0.13 is 72.9% below this industry median. Based on the distribution chart, LifeMD ranks #596 out of 684 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, LifeMD has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does LifeMD's Equity-to-Asset compare to AMWL and SY?
According to the Healthcare Providers & Services industry distribution chart, LifeMD ranks #596 out of 684 companies for Equity-to-Asset. This places LifeMD in the lower half of its industry. The industry median Equity-to-Asset is 0.48. LifeMD's value of 0.13 is 72.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.48, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LifeMD's current Equity-to-Asset of 0.13 is 72.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on LifeMD and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LifeMD's current Equity-to-Asset is 0.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeMD stock overvalued right now?
Based on GuruFocus' analysis, LifeMD (LFMD) is currently considered Possible Value Trap. The stock's GF Value™ is $5.11, compared to a current price of $3.32 — trading 35% below its estimated fair value. The current Equity-to-Asset is 0.13 and 72.9% below the Healthcare Providers & Services industry median of 0.48. LifeMD's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For LifeMD (LFMD), the current Equity-to-Asset is 0.13 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeMD (LFMD) Overvalued in 2026?
Based on GuruFocus' analysis, LifeMD stock appears to be undervalued.
The current stock price of $3.32 is trading 35% below its estimated GF Value™ of $5.11.
GuruFocus considers LifeMD to be Possible Value Trap.
Key valuation signals for LFMD:
Equity-to-Asset: 0.13
GF Value™: $5.11 vs. price of $3.32 (35% below fair value)
Industry Position: 72.9% below the Healthcare Providers & Services median (#596 of 684)
No single metric tells the full story. See the LFMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.
73GF Score
Get the complete analysis for LFMD
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LFMD has been successfully added to your 
